Axon Enterprise, Inc. (NASDAQ:AXON) Stock Position Increased by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 58.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 361 shares of the biotechnology company’s stock after buying an additional 133 shares during the period. Smartleaf Asset Management LLC’s holdings in Axon Enterprise were worth $218,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Asset Dedication LLC grew its holdings in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its stake in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares in the last quarter. Venturi Wealth Management LLC increased its holdings in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after purchasing an additional 21 shares during the period. Insigneo Advisory Services LLC raised its stake in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC lifted its holdings in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after purchasing an additional 24 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on AXON. Needham & Company LLC restated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Barclays set a $726.00 price objective on Axon Enterprise and gave the stock an “overweight” rating in a research note on Thursday, February 27th. Finally, TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Activity

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the business’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the sale, the president now directly owns 181,892 shares in the company, valued at approximately $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,146 shares of company stock worth $3,262,847 over the last 90 days. 6.10% of the stock is owned by company insiders.

Axon Enterprise Price Performance

NASDAQ AXON opened at $534.96 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The company has a market cap of $40.79 billion, a PE ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. The stock’s 50-day moving average price is $605.52 and its two-hundred day moving average price is $527.52.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.